Aldehydes and disturbance of carbohydrate metabolism: Some consequences and possible approaches to its normalization
Authors:
- 1 January 2007
- journal article
- research article
- Published by Taylor & Francis in Archives of Physiology and Biochemistry
- Vol. 113 (2) , 87-95
Abstract
There are many well-documented errors of metabolism involving genetic defects that affect carbohydrate utilization. The array of disorders includes the defective utilization of glucose, as well as enzymatic deficiencies in glycolysis and gluconeogenesis, and the pentose phosphate pathway. Besides, there is considerable literature about metabolic syndrome and diabetes. However, the main problem of their origin remains obscure. Also, it is presently beyond doubt that there are various causes of insulin resistance. The development of insulin resistance may be associated not only with insulin production disorders or presence of insulin antagonists but also with modification of the number of receptors and sensitivity of peripheral tissues. The insulin resistance originates from insulin signal transmission defects at its initial stages. It is presently uncertain which mechanisms of adaptation regulation are activated or should be activated under hyperglycemia conditions. This is the main problem of the selection of strategy of hyperglycemia treatment but it is important that aldehydes—the secondary products of lipid peroxidation and protein glycation (malondialdehyde and methylglyoxal)—make a contribution to abnormal metabolism. As far as the role of methylglyoxal in inhibition of antioxidant enzymes is concerned, the involvement of the ketoaldehyde in such processes as oxidative stress, cell proliferation control, and carbohydrate metabolism disorders does not cast any doubt.Keywords
This publication has 72 references indexed in Scilit:
- Glucose-induced Effects and Joker Function of Glucose: Endocrine or Genotoxic Prevalence?Hormone and Metabolic Research, 2006
- Cumene peroxide and Fe2+-ascorbate-induced lipid peroxidation and effect of phosphoglucose isomeraseMolecular and Cellular Biochemistry, 2006
- The Cellular Fate of Glucose and Its Relevance in Type 2 DiabetesEndocrine Reviews, 2004
- Glyceraldehyde-3-phosphate dehydrogenase activity as an independent modifier of methylglyoxal levels in diabetesBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2003
- Molecular Mechanisms of the Cross-Impact of Pathological Processes in Combined Diabetes and Cancer. Research and Clinical AspectsBiochemistry (Moscow), 2002
- Passive cigarette smoke and renal glyoxalase systemMolecular and Cellular Biochemistry, 2002
- Glyoxal and methylglyoxal trigger distinct signals for map family kinases and caspase activation in human endothelial cellsFree Radical Biology and Medicine, 2001
- Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liverNature, 2001
- Metformin reduces systemic methylglyoxal levels in type 2 diabetes.Diabetes, 1999
- Insulin differentially regulates systemic and skeletal muscle vascular resistanceAmerican Journal of Physiology-Endocrinology and Metabolism, 1993